Completed in 2019, this pharmaceutical facility was built on a 3,500 m² site in the Baharestan Industrial Zone, Alborz Province. Initially planned for the production of solid dosage medications, the project later evolved into Iran’s first plasma-derived pharmaceutical manufacturing center.